Cargando…

Immunosenescence in neurocritical care

BACKGROUND: Several advanced and developing countries are now entering a superaged society, in which the percentage of elderly people exceeds 20% of the total population. In such an aging society, the number of age-related diseases such as malignant tumors, diabetes, and severe infections including...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Shigeaki, Saito, Masafumi, Kotani, Joji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186132/
https://www.ncbi.nlm.nih.gov/pubmed/30349725
http://dx.doi.org/10.1186/s40560-018-0333-5
_version_ 1783362818239627264
author Inoue, Shigeaki
Saito, Masafumi
Kotani, Joji
author_facet Inoue, Shigeaki
Saito, Masafumi
Kotani, Joji
author_sort Inoue, Shigeaki
collection PubMed
description BACKGROUND: Several advanced and developing countries are now entering a superaged society, in which the percentage of elderly people exceeds 20% of the total population. In such an aging society, the number of age-related diseases such as malignant tumors, diabetes, and severe infections including sepsis is increasing, and patients with such disorders often find themselves in the ICU. MAIN BODY: Age-related diseases are closely related to age-induced immune dysfunction, by which reductions in the efficiency and specificity of the immune system are collectively termed “immunosenescence.” The most noticeable is a decline in the antigen-specific acquired immune response. The exhaustion of T cells in elderly sepsis is related to an increase in nosocomial infections after septicemia, and even death over subacute periods. Another characteristic is that senescent cells that accumulate in body tissues over time cause chronic inflammation through the secretion of proinflammatory cytokines, termed senescence-associated secretory phenotype. Chronic inflammation associated with aging has been called “inflammaging,” and similar age-related diseases are becoming an urgent social problem. CONCLUSION: In neuro ICUs, several neuro-related diseases including stroke and sepsis-associated encephalopathy are related to immunosenescence and neuroinflammation in the elderly. Several advanced countries with superaged societies face the new challenge of improving the long-term prognosis of neurocritical patients.
format Online
Article
Text
id pubmed-6186132
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61861322018-10-22 Immunosenescence in neurocritical care Inoue, Shigeaki Saito, Masafumi Kotani, Joji J Intensive Care Review BACKGROUND: Several advanced and developing countries are now entering a superaged society, in which the percentage of elderly people exceeds 20% of the total population. In such an aging society, the number of age-related diseases such as malignant tumors, diabetes, and severe infections including sepsis is increasing, and patients with such disorders often find themselves in the ICU. MAIN BODY: Age-related diseases are closely related to age-induced immune dysfunction, by which reductions in the efficiency and specificity of the immune system are collectively termed “immunosenescence.” The most noticeable is a decline in the antigen-specific acquired immune response. The exhaustion of T cells in elderly sepsis is related to an increase in nosocomial infections after septicemia, and even death over subacute periods. Another characteristic is that senescent cells that accumulate in body tissues over time cause chronic inflammation through the secretion of proinflammatory cytokines, termed senescence-associated secretory phenotype. Chronic inflammation associated with aging has been called “inflammaging,” and similar age-related diseases are becoming an urgent social problem. CONCLUSION: In neuro ICUs, several neuro-related diseases including stroke and sepsis-associated encephalopathy are related to immunosenescence and neuroinflammation in the elderly. Several advanced countries with superaged societies face the new challenge of improving the long-term prognosis of neurocritical patients. BioMed Central 2018-10-12 /pmc/articles/PMC6186132/ /pubmed/30349725 http://dx.doi.org/10.1186/s40560-018-0333-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Inoue, Shigeaki
Saito, Masafumi
Kotani, Joji
Immunosenescence in neurocritical care
title Immunosenescence in neurocritical care
title_full Immunosenescence in neurocritical care
title_fullStr Immunosenescence in neurocritical care
title_full_unstemmed Immunosenescence in neurocritical care
title_short Immunosenescence in neurocritical care
title_sort immunosenescence in neurocritical care
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186132/
https://www.ncbi.nlm.nih.gov/pubmed/30349725
http://dx.doi.org/10.1186/s40560-018-0333-5
work_keys_str_mv AT inoueshigeaki immunosenescenceinneurocriticalcare
AT saitomasafumi immunosenescenceinneurocriticalcare
AT kotanijoji immunosenescenceinneurocriticalcare